AGP
PFE icon

Autumn Glory Partners’s Pfizer PFE Stock Holding History

Autumn Glory Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.59M Buy
66,212
+2,026
+3% +$53K 0.45% 58
2026
Q1 		$1.8M Buy
64,186
+11,301
+21% +$301K 0.66% 39
2025
Q4 		$1.32M Buy
52,885
+15,010
+40% +$379K 0.46% 64
2025
Q3 		$965K Hold
37,875
– – 0.4% 72
2025
Q2 		$918K Hold
37,875
– – 0.43% 67
2025
Q1 		$960K Sell
37,875
-1,284
-3% -$33.6K 0.48% 61
2024
Q4 		$1.05M Buy
39,159
+8,909
+29% +$242K 0.51% 60
2024
Q3 		$875K Buy
30,250
+16,875
+126% +$492K 0.34% 80
2024
Q2 		$374K Buy
13,375
+2,355
+21% +$64.8K 0.19% 107
2024
Q1 		$306K Buy
+11,020
New +$306K 0.15% 119
2023
Q3 		– Sell
-8,760
Closed -$321K – 164
2023
Q2 		$321K Buy
+8,760
New +$341K 0.24% 97
2023
Q1 		– Sell
-18,459
Closed -$946K – 172
2022
Q4 		$946K Buy
18,459
+8,471
+85% +$406K 0.51% 60
2022
Q3 		$437K Sell
9,988
-4,739
-32% -$230K 0.29% 85
2022
Q2 		$772K Buy
14,727
+5,145
+54% +$262K 0.57% 52
2022
Q1 		$496K Sell
9,582
-6,713
-41% -$348K 0.29% 99
2021
Q4 		$963K Buy
+16,295
New +$807K 0.4% 68

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Autumn Glory Partners's PFE Position: Q2 2026 in Review

Autumn Glory Partners increased its Pfizer (PFE) stake by 3.2% in Q2 2026, buying an estimated $53K and bringing the position to 66,212 shares worth $1.59M. The position accounts for 0.45% of the portfolio, ranked #58.

Autumn Glory Partners first reported a position in PFE in Q4 2021 and has held it in 16 quarters since. The position peaked at $1.8M in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Autumn Glory Partners held 66,212 shares of Pfizer worth $1.59M as of Q2 2026.
  • Autumn Glory Partners bought 2,026 Pfizer shares in Q2 2026, an estimated $53K.
  • Pfizer made up 0.45% of Autumn Glory Partners's portfolio in Q2 2026, its #58 holding.
  • Autumn Glory Partners first reported a position in Pfizer in Q4 2021 and has held it in 16 quarters since.
  • Autumn Glory Partners's Pfizer position peaked at $1.8M in Q1 2026.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Autumn Glory Partners's 13F filing for Q2 2026, filed 3 Aug 2026.